Webinars
Register for upcoming webinars and watch recordings of past events. Interested in putting on your own live webinar? Talk to us.
Shaping the Future of Drug Development
LIVE WEBINAR | APRIL 23 | 1PM–2PM EST
In this discussion, our guests explore how recent regulatory changes are shaping the future of AI in drug development in the US market. We will also discuss the ripple effect these changes are having on a global scale. Our guests will provide their insights from investor, regulatory and legal perspectives to unpack the latest changes to guidance and communications their impacts on market and development strategies, cross-border collaboration, and legal frameworks.
LIVE WEBINAR | APRIL 23 | 1PM–2PM EST
In this discussion, our guests explore how recent regulatory changes are shaping the future of AI in drug development in the US market. We will also discuss the ripple effect these changes are having on a global scale. Our guests will provide their insights from investor, regulatory and legal perspectives to unpack the latest changes to guidance and communications their impacts on market and development strategies, cross-border collaboration, and legal frameworks.
Surviving and Thriving in the Never-ending Biotech Downturn
LIVE WEBINAR | MAY 20 | 2PM–3PM EST
The rumors of biotech’s return have been greatly exaggerated. Despite some M&A sparks, a handful of mega fundraises and a trickle of IPOs, the biotech industry continues to climb out of a multi-year down period. So how does a company thrive in this environment?
BioSpace sits down with four NextGen companies doing just that, to hear about ways they are defying the odds to churn out clinical data that may finally provide the industry with a ladder out.
LIVE WEBINAR | MAY 20 | 2PM–3PM EST
The rumors of biotech’s return have been greatly exaggerated. Despite some M&A sparks, a handful of mega fundraises and a trickle of IPOs, the biotech industry continues to climb out of a multi-year down period. So how does a company thrive in this environment?
BioSpace sits down with four NextGen companies doing just that, to hear about ways they are defying the odds to churn out clinical data that may finally provide the industry with a ladder out.
This webinar will help you discover effective strategies for launching your career in biotechnology. You will gain valuable insights from industry experts and leave with the essential tools you need to thrive in this dynamic field.
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
Join our webinar to explore strategies, best practices, and the evolving landscape of QARA in today’s dynamic market.
This discussion features DEIB leaders from California Life Sciences, MassBio, Eli Lilly and Takeda. We explore changing attitudes in the life sciences workforce, if organizations are adjusting either their DEIB or communication strategies, and how evolving philosophies around DEIB are impacting human resources and talent acquisition activities.
Join us in this discussion on how you can optimize your chances of landing a new role despite a highly competitive job market.
BioSpace and guests from Halia Therapeutics, Triumvira Immunologics and the Alzheimer’s Drug Discovery Foundation will discuss alternative financing strategies to consider for 2024. Watch now.
Watch this webinar to gain insights from expert speakers, Dr. Iris Alroy and Dr. Kristopher Brannan, who have made significant advancements in the field of RBPs.
In BioSpace’s latest webinar, we covered topics including proactive recruitment strategies, remote hiring, compensation negotiating and employee retention.
In this webinar, we discuss how to create policies that are fair for both remote and local workers; vaccination policies; travel policies; communication strategies and managing employee relations in regards to these changes.
BioSpace was thrilled to host a virtual panel discussion to hear how workplaces can improve their D&I strategies and help organizations thrive. We heard insightful advice from panelists from Amgen, Intellia Therapeutics, Obsidian Therapeutics, Omega Therapeutics and Athira Pharma.
PRESS RELEASES